Coherus BioSciences, Inc.
CHRS
$0.7818
-$0.0349-4.27%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 28.51M | -450.00K | -29.34M | -59.29M | -237.89M |
| Total Depreciation and Amortization | 5.28M | 5.31M | 4.66M | 4.35M | 3.79M |
| Total Amortization of Deferred Charges | 4.16M | 2.41M | 2.41M | 2.41M | 2.41M |
| Total Other Non-Cash Items | -114.28M | -76.97M | -73.63M | -61.53M | 93.64M |
| Change in Net Operating Assets | 55.89M | 7.73M | 41.64M | -38.86M | -36.83M |
| Cash from Operations | -20.44M | -61.99M | -54.27M | -152.92M | -174.88M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 0.00 | 7.00M | 7.00M | 7.00M |
| Divestitures | 227.82M | 227.82M | 227.82M | 187.82M | -- |
| Other Investing Activities | 2.50M | 38.24M | 81.35M | 135.06M | 137.64M |
| Cash from Investing | 230.32M | 266.07M | 316.17M | 329.88M | 144.64M |
| Total Debt Issued | 36.98M | 36.98M | 37.12M | -- | -- |
| Total Debt Repaid | -260.39M | -260.39M | -260.39M | -- | -- |
| Issuance of Common Stock | 2.67M | 3.32M | 14.81M | 69.08M | 74.22M |
| Repurchase of Common Stock | -2.48M | -2.79M | -2.96M | -1.55M | -3.59M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 36.24M | 36.04M | 35.85M | -847.00K | -1.03M |
| Cash from Financing | -186.97M | -186.84M | -175.57M | 66.68M | 69.60M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 22.91M | 17.24M | 86.33M | 243.64M | 39.36M |
